| |
| |
|
| Insider
Information: |
Schall Thomas J. |
| Relationship: |
|
| City: |
Mountain View |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
2,900 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
2,900 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Chemocentryx, Inc. |
CCXI |
President and CEO, Dir... |
2022-10-20 |
0 |
|
0 |
Premium* |
|
|
Immuneering Corp |
IMRX |
|
2024-03-22 |
2,900 |
2024-03-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
144 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CCXI |
Chemocentryx, Inc. |
President, CEO and DirectorOff |
• • • |
2012-02-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,316,667 |
|
- |
|
| CCXI |
Chemocentryx, Inc. |
President and CEO |
• • – |
2013-03-18 |
4 |
AS |
$13.75 |
$1,031 |
D/D |
(75) |
2,181,972 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
President and CEO |
• • – |
2018-06-29 |
4 |
AS |
$14.10 |
$1,410 |
D/D |
(100) |
2,184,994 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
President and CEO |
• • – |
2018-06-29 |
4 |
OE |
$6.00 |
$600 |
D/D |
100 |
2,185,094 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
President and CEO |
• • – |
2013-04-02 |
4 |
AS |
$14.00 |
$2,800 |
D/D |
(200) |
2,181,216 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
President and CEO |
• • – |
2013-04-10 |
4 |
AS |
$14.00 |
$3,038 |
D/D |
(217) |
2,180,999 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
President and CEO |
• • – |
2013-07-01 |
4 |
AS |
$14.50 |
$4,510 |
D/D |
(311) |
2,170,776 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
President and CEO |
• • – |
2013-03-14 |
4 |
AS |
$14.00 |
$5,908 |
D/D |
(422) |
2,198,773 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
President and CEO |
• • – |
2013-04-01 |
4 |
AS |
$14.00 |
$7,784 |
D/D |
(556) |
2,181,416 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
President and CEO |
• • – |
2015-03-25 |
4 |
AS |
$7.57 |
$6,812 |
D/D |
(900) |
2,148,667 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
President and CEO |
• • – |
2015-03-25 |
4 |
OE |
$0.60 |
$540 |
D/D |
900 |
2,149,567 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
President and CEO |
• • – |
2012-11-20 |
4 |
AS |
$12.01 |
$11,997 |
D/D |
(999) |
2,238,667 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
President and CEO |
• • – |
2012-11-19 |
4 |
AS |
$12.02 |
$13,232 |
D/D |
(1,101) |
2,239,666 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
President and CEO |
• • – |
2013-03-06 |
4 |
AS |
$14.00 |
$16,156 |
D/D |
(1,154) |
2,210,626 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
President and CEO |
• • – |
2015-03-30 |
4 |
AS |
$7.51 |
$9,009 |
D/D |
(1,200) |
2,148,667 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
President and CEO |
• • – |
2015-03-30 |
4 |
OE |
$0.60 |
$720 |
D/D |
1,200 |
2,149,867 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
President and CEO |
• • – |
2013-03-05 |
4 |
AS |
$14.03 |
$18,593 |
D/D |
(1,323) |
2,211,780 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
President and CEO |
• • – |
2013-03-13 |
4 |
AS |
$14.00 |
$27,720 |
D/D |
(1,980) |
2,199,195 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
President and CEO |
• • – |
2012-11-16 |
4 |
AS |
$12.00 |
$24,000 |
D/D |
(2,000) |
2,240,767 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
President and CEO |
• • – |
2020-06-15 |
4 |
OE |
$14.31 |
$28,620 |
D/D |
2,000 |
2,270,557 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
President and CEO |
• • – |
2020-06-15 |
4 |
AS |
$65.04 |
$130,090 |
D/D |
(2,000) |
2,268,557 |
0 |
% |
|
| CCXI |
Chemocentryx, Inc. |
President and CEO |
• • – |
2013-04-11 |
4 |
AS |
$14.02 |
$32,409 |
D/D |
(2,312) |
2,178,687 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
President and CEO |
• • – |
2013-03-12 |
4 |
AS |
$14.00 |
$35,042 |
D/D |
(2,503) |
2,201,175 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
President and CEO |
• • – |
2013-07-16 |
4 |
AS |
$14.54 |
$37,595 |
D/D |
(2,585) |
2,148,687 |
0 |
- |
|
| IMRX |
Immuneering Corp |
|
– • – |
2024-03-22 |
4 |
B |
$2.55 |
$7,385 |
D/D |
2,900 |
2,900 |
0.01 |
- |
|
144 Records found
|
|
Page 1 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
